S K Field

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. ncbi New treatment options for multidrug-resistant tuberculosis
    Stephen K Field
    Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, Canada
    Ther Adv Respir Dis 6:255-68. 2012
  2. ncbi Mycobacterium avium complex pulmonary disease in patients without HIV infection
    Stephen K Field
    Division of Respiratory Medicine, University of Calgary Medical School, Calgary, AB, Canada
    Chest 126:566-81. 2004
  3. ncbi Steroids and/or cytotoxic agents should be used early in the management of patients with IPF - the con argument
    Stephen K Field
    Division of Respirology, University of Calgary, Health Science Centre, Alberta
    Can Respir J 11:212-3. 2004
  4. ncbi Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
    Stephen K Field
    Foothills Medical Centre and Tuberculosis Services, Calgary Health Region, Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, T2N 4N1, Canada
    Expert Opin Investig Drugs 17:811-8. 2008
  5. ncbi Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial
    Stephen K Field
    Calgary COPD and Asthma Program and Division of Respirology, Calgary Health Region, The University of Calgary, Calgary, AB, Canada
    Chest 136:1021-8. 2009
  6. ncbi Assessment and management of patients with chronic cough by Certified Respiratory Educators: a randomized controlled trial
    S K Field
    Calgary Health Region, University of Calgary, Calgary, Canada
    Can Respir J 16:49-54. 2009
  7. ncbi Gastroesophageal reflux and asthma: can the paradox be explained?
    S K Field
    University of Calgary Medical School, Calgary, Canada
    Can Respir J 7:167-76. 2000
  8. ncbi Gastroesophageal reflux and asthma: are they related?
    S K Field
    Division of Respirology, University of Calgary Medical School and the Calgary Asthma Program, Alberta, Canada
    J Asthma 36:631-44. 1999
  9. ncbi The effects of antireflux surgery on asthmatics with gastroesophageal reflux
    S K Field
    Department of Medicine, University of Calgary Medical School, Alberta, Canada
    Chest 116:766-74. 1999
  10. ncbi Lung disease due to the more common nontuberculous mycobacteria
    Stephen K Field
    Division of Respiratory Medicine, University of Calgary Medical School and Tuberculosis Services, Calgary Health Region, Calgary, AB, Canada
    Chest 129:1653-72. 2006

Detail Information

Publications21

  1. ncbi New treatment options for multidrug-resistant tuberculosis
    Stephen K Field
    Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, Canada
    Ther Adv Respir Dis 6:255-68. 2012
    ..A number of novel drugs are undergoing clinical testing and will hopefully be available in the near future. These include the newer oxazolidinones, diarylquinolines, nitroimidazopyrans, ethenylenediamines, pyrroles, and benzothiazinones...
  2. ncbi Mycobacterium avium complex pulmonary disease in patients without HIV infection
    Stephen K Field
    Division of Respiratory Medicine, University of Calgary Medical School, Calgary, AB, Canada
    Chest 126:566-81. 2004
    ..The prolonged treatment period, side effects, and possibly reinfection rather than relapse are responsible for the high failure rate...
  3. ncbi Steroids and/or cytotoxic agents should be used early in the management of patients with IPF - the con argument
    Stephen K Field
    Division of Respirology, University of Calgary, Health Science Centre, Alberta
    Can Respir J 11:212-3. 2004
  4. ncbi Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
    Stephen K Field
    Foothills Medical Centre and Tuberculosis Services, Calgary Health Region, Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, T2N 4N1, Canada
    Expert Opin Investig Drugs 17:811-8. 2008
    ..Studies in asthma and chronic obstructive pulmonary disease (COPD) have demonstrated that it can improve lung function and reduce inflammation...
  5. ncbi Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial
    Stephen K Field
    Calgary COPD and Asthma Program and Division of Respirology, Calgary Health Region, The University of Calgary, Calgary, AB, Canada
    Chest 136:1021-8. 2009
    ..This study was undertaken to see whether CREs could assist pulmonologists (MDs) in managing patients with chronic cough...
  6. ncbi Assessment and management of patients with chronic cough by Certified Respiratory Educators: a randomized controlled trial
    S K Field
    Calgary Health Region, University of Calgary, Calgary, Canada
    Can Respir J 16:49-54. 2009
    ..In the present study, a prospective, randomized, controlled study was undertaken to determine whether Certified Respiratory Educators (CREs) could manage screened patients with chronic cough as effectively as respirologists...
  7. ncbi Gastroesophageal reflux and asthma: can the paradox be explained?
    S K Field
    University of Calgary Medical School, Calgary, Canada
    Can Respir J 7:167-76. 2000
    ..The purpose of this paper is to review the evidence for a relationship between the two conditions...
  8. ncbi Gastroesophageal reflux and asthma: are they related?
    S K Field
    Division of Respirology, University of Calgary Medical School and the Calgary Asthma Program, Alberta, Canada
    J Asthma 36:631-44. 1999
    ..The paradox of GER causing asthma symptoms but not changing pulmonary function may be explained by its increasing minute ventilation rather than triggering bronchospasm...
  9. ncbi The effects of antireflux surgery on asthmatics with gastroesophageal reflux
    S K Field
    Department of Medicine, University of Calgary Medical School, Alberta, Canada
    Chest 116:766-74. 1999
    ..The purpose of this article is to review the available literature on the effects of antireflux surgery in asthma...
  10. ncbi Lung disease due to the more common nontuberculous mycobacteria
    Stephen K Field
    Division of Respiratory Medicine, University of Calgary Medical School and Tuberculosis Services, Calgary Health Region, Calgary, AB, Canada
    Chest 129:1653-72. 2006
    ..The purpose of this article is to review the common presentations of NTM lung disease, the conditions associated with NTM lung disease, and the clinical features and treatment of the NTM that most commonly cause lung disease...
  11. ncbi Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
    Mark A Giembycz
    Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, Alberta, Canada
    Drug Des Devel Ther 4:147-58. 2010
    ..Roflumilast is the first selective phosphodiesterase 4 inhibitor and will offer physicians another treatment option for patients with more severe COPD...
  12. ncbi A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults
    S K Field
    Foothills Medical Centre, Calgary, Alberta, Canada
    Chest 115:848-56. 1999
    ..To identify and critically review the published peer-reviewed, English-language studies of the effects of both spontaneous and simulated gastroesophageal reflux (GER) on pulmonary function in asthmatic adults...
  13. ncbi Inhaled corticosteroid therapy does not control asthma
    Robert L Cowie
    Calgary COPD and Asthma Program, University of Calgary, Calgary, Canada
    Can Respir J 11:555-8. 2004
    ..Randomized clinical trials demonstrate efficacy and show that inhaled corticosteroid therapy can control asthma, but details concerning their effectiveness in achieving this goal in the community are lacking...
  14. ncbi A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis
    Alain Tremblay
    Alain Tremblay, MDUniversity of Calgary, Calgary, AB, Canada
    Chest 136:340-6. 2009
    ..The aim of this study was to compare the diagnostic yield of EBUS-guided TBNA to TBNA performed with a standard 19-gauge needle in patients with mediastinal adenopathy and a clinical suspicion of sarcoidosis...
  15. ncbi Asthma symptoms do not predict spirometry
    Robert L Cowie
    University of Calgary, Calgary, Alberta
    Can Respir J 14:339-42. 2007
    ..Asthma is a disease characterized by variable airflow obstruction, but the measurement of airflow is often omitted in the process of diagnosis and management of the disease...
  16. ncbi Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility
    H Yang
    Tuberculosis Services, University of Calgary, Calgary, Alberta, Canada
    Int J Tuberc Lung Dis 9:288-93. 2005
    ..Drug-resistant strains of TB were more common in foreign-born and previously treated patients...
  17. ncbi Predicting emergency department utilization in adults with asthma: a cohort study
    R L Cowie
    Calgary Asthma Program, University of Calgary, Alberta, Canada
    J Asthma 38:179-84. 2001
    ..D. asthma treatment since entry to the cohort. This study suggests that special attention should be paid to subjects with asthma that interferes with their lifestyle and to those who have needed hospital admission for asthma...
  18. ncbi Underlying mechanisms of respiratory symptoms with esophageal acid when there is no evidence of airway response
    S K Field
    Department of Medicine, Division of Respiratory Medicine, University of Calgary Medical School, Calgary, Alberta, Canada T2N 2T9
    Am J Med 111:37S-40S. 2001
    ..Treating GER, either medically or surgically, may improve asthma symptoms by preventing GER-induced changes in minute ventilation...
  19. ncbi Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
    Stephen K Field
    Division of Respiratory Medicine University of Calgary Medical School and Calgary Health Region Tuberculosis Services, Calgary, AB, Canada
    Chest 124:1482-6. 2003
    ..Mycobacterium avium-intracellulare (MAC) causes progressive lung disease. Recommended treatment regimens include a macrolide and a rifamycin, but drug intolerance and relapse after treatment is completed often limit successful therapy...
  20. ncbi Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial
    Toni O Kiljander
    Department of Pulmonary Diseases, Tampere University Hospital, FIN 33521, Tampere, Finland
    Am J Respir Crit Care Med 173:1091-7. 2006
    ..Gastroesophageal reflux disease (GERD) is common in patients with asthma, suggesting an interaction between the two conditions...
  21. ncbi Asthma and gastroesophageal reflux: another piece in the puzzle?
    Stephen K Field
    Chest 121:1024-7. 2002